Clinical Trial Update: Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating dupilumab for efficacy in nummular eczema. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nummular Eczema

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Technical University of Munich | Conditions: Nummular Eczema | Phase 2 | Status: ACTIVE_NOT_RECRUITING